What role does stereotactic ablative radiotherapy have in advanced castrate-resistant prostate cancer?

被引：2
|
作者：
Phillips, Ryan [1 ]
Ost, Piet [2 ]
Tran, Phuoc T. [1 ,3 ,4 ]
机构：
[1] Johns Hopkins Univ, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA
[2] Univ Ghent, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium
[3] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA
[4] Johns Hopkins Univ, Dept Urol, Baltimore, MD 21218 USA
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 24期
关键词：
castration-resistant prostate cancer; neoplasm metastasis; neoplasm recurrence; oligometastasis; prostate cancer; stereotactic ablative radiotherapy; stereotactic body radiation therapy; ANDROGEN DEPRIVATION; BODY RADIOTHERAPY; LUNG-CANCER; THERAPY; HISTORY;
D O I：
10.2217/fon-2017-0337
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：2121 / 2124
页数：4
相关论文
共 50 条
  • [1] Complete PSA Response Following Stereotactic Ablative Radiotherapy for a Bony Metastasis in the Setting of Castrate-Resistant Prostate Cancer
    Lukovic, Jelena
    Rodrigues, George
    CUREUS, 2015, 7 (10):
  • [2] Stereotactic ablative body radiotherapy for oligometastatic inguinal lymph node in castrate resistant prostate cancer
    Goyal, Shikha
    Periasamy, Kannan
    Madan, Renu
    Vias, Poorva
    Chandran, Vigneshwaran
    ASIAN JOURNAL OF UROLOGY, 2023, 10 (01) : 109 - 112
  • [3] Recomendations on the Management of Controversies in Advanced Castrate-Resistant Prostate Cancer
    Cozar, J. M.
    Solsona, E.
    Morote, J.
    Minana, B.
    Maroto, J. P.
    Gonzalez del Alba, A.
    Climent, M. A.
    Carles, J.
    Alcaraz, A.
    Castellano, D.
    ACTAS UROLOGICAS ESPANOLAS, 2012, 36 (10): : 569 - 577
  • [4] Treatment of castrate-resistant prostate cancer - What is the best management?
    Uemura, Hirotsugu
    Reiter, Robert
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (04) : 427 - 427
  • [5] Castrate-Resistant Prostate Cancer Foreword
    Taneja, Samir S.
    UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : XIII - XIII
  • [6] Metastatic castrate-resistant prostate cancer
    Schellhammer, Paul
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) : 51 - 52
  • [7] Treatment of Castrate-Resistant Prostate Cancer
    Logothetis, Christopher J.
    JOURNAL OF UROLOGY, 2013, 190 (02): : 439 - 440
  • [8] Castrate-Resistant Prostate Cancer Preface
    Kibel, Adam S.
    UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : XV - XV
  • [9] Potential role of rituximab in metastatic castrate-resistant prostate cancer
    Bindal, Poorva
    Jalil, Sharif A. A.
    Holle, Lisa M.
    Clement, Jessica M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (06) : 1509 - 1511
  • [10] Phase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation for Patients with Metastatic Castrate-Resistant Prostate Cancer
    Hannan, Raquibul
    Dohopolski, Michael J.
    Pop, Laurentiu M.
    Mannala, Samantha
    Watumull, Lori
    Mathews, Dana
    Gao, Ang
    Garant, Aurelie
    Arriaga, Yull E.
    Bowman, Isaac
    Chung, Jin-Sung
    Wang, Jing
    Ariizumi, Kiyoshi
    Ahn, Chul
    Timmerman, Robert
    Courtney, Kevin
    BIOMEDICINES, 2022, 10 (06)
12345